Pivaris BioScience GmbH
Facts
- Founded
- 2019
- Staff
- 1
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
Profile
R&D:A novel, broad-acting antiviral peptide targeting double-stranded DNA viruses such as herpes simplex virus, cytomegalovirus, vaccinia virus, polyomavirus and adenoviruses has been identified. This first-in-class inhibitor is currently being optimized and evaluated for its use in the systemic treatment of infections caused by double-stranded DNA viruses. The proprietary lead candidate of Pivaris BioScience GmbH is also being evaluated for its efficacy against various RNA viruses.
Similar companies in RDM biotech/pharma
CALYXHA Biotechnologies GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Focus
- human health
Neurolentech GmbH
- Organization type
- RDM biotech/pharma
- Region
- Lower Austria
- Focus
- human health
CYL Pharmazeutika GmbH
- Organization type
- RDM biotech/pharma
- Region
- Styria
- Focus
- human health
ProFem GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- human health
Contact
MQM 3.4, Maria-Jacobi Gasse 1, 5. Stock
1030 Wien
Vienna
Contact:
Telephone: 436647623797
Email: Hanna.Harant@pivaris-bioscience.at
Website